![Renejix CDMO Partner for Small Molecule Oral Dosage Forms](https://www.pharmacompass.com/image/flap/renejix-w35-desktop-header-01gif-33629.gif)
![Renejix CDMO Partner for Small Molecule Oral Dosage Forms](https://www.pharmacompass.com/image/flap/renejix-w35-mob-header-01gif-17728.gif)
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.prnewswire.com/news-releases/synendos-therapeutics-ag-granted-ema-clinical-trial-authorisation-for-first-in-class-endocannabinoid-system-modulator-syt-510-302037349.html
https://www.prnewswire.com/news-releases/synendos-therapeutics-ag-co-founder-and-sab-member-professor-jurg-gertsch-presents-groundbreaking-new-findings-on-an-endocannabinoid-transporter-at-cannabinoid-research-conference-301878746.html
https://www.pharmacompass.com/pdf/news/synendos-therapeutics-expands-series-a-to-chf-24-million-with-new-investment-1622119841.pdf
https://www.prnewswire.com/news-releases/synendos-therapeutics-expands-series-a-to-chf-24-million-with-new-investment-301271711.html